Abstract
The paper considers insulin’s specific action on the patient’s body, types of insulin preparations and insulin analogues which are used for the treatment of diabetes, as well as applicable requirements for these products. It was demonstrated that determination of biological activity is one of the key quality parameters of this type of medicines. The paper summarises the methods used for evaluation of insulin and its analogues, which are based both on the hormone’s general action on the body (in vivo: double crossing, euglycemic clamp, etc.), and on certain aspects of the hormone’s interaction with the body systems (in vitro: receptor-binding assay, phosphorylation, metabolic methods). Due to the appearance of insulin biosimilars on the pharmaceutical market, the article raises the issue that the «Biological potency» parameter tested in animals should be kept as part of the product specification. The analysis of the in vivo and in vitro methods of biological activity determination convincingly demonstrates that animal models can not be replaced with the modern analytical methods based on cell cultures. Consequently, animal models are still necessary, as they allow for an adequate assessment of the quality of insulins in terms of «Biological potency». Taking into account the global trend towards reduction of animal testing, the authors point out the need to develop modern methods, the results of which will be comparable to the results of in vivo determination of the biological activity.
Highlights
Инсулин относится к полипептидным гормонам, и его основное действие направлено на поддержание углеводного баланса
The paper considers insulin’s specific action on the patient’s body, types of insulin preparations and insulin analogues which are used for the treatment of diabetes, as well as applicable requirements for these products
The paper summarises the methods used for evaluation of insulin and its analogues, which are based both on the hormone’s general action on the body, and on certain aspects of the hormone’s interaction with the body systems
Summary
Испытание на экспериментальных животных (эугликемический клэмп) Animal test (euglycaemic clamp). Испытание на экспериментальных животных (внутривенное введение) Animal test (intravenous). Испытание на экспериментальных животных (подкожное введение) Animal test (subcutaneous). 1. Схема действия инсулина в организме и методы его оценки в условиях in vivo и на отдельных этапах in vitro. The schematic illustration of insulin action and methods of its assessment in vivo and, at some stages, in vitro. Vølund et al [9]. В то же время во многих странах мира регистрация биоподобных препаратов проходит на основании упрощенной заявки, которая принята для воспроизведенных препаратов [13,14,15]. Для количественного определения биологической активности инсулина и его аналогов in vivo необходимо использование соответствующих стандартных образцов, аттестованных по данному показателю
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
